Insulinlike growth factor-binding protein modulates the growth response to insulinlike growth factor 1 by human gastric cancer cells. Guo YS, Beauchamp RD, Jin GF, Townsend CM, Thompson JC (1993) Gastroenterology 104: 1595-604 Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins. Guix M, Faber AC, Wang SE, Olivares MG, Song Y, Qu S, Rinehart C, Seidel B, Yee D, Arteaga CL, Engelman JA (2008) J Clin Invest 118: 2609-19 Linkage disequilibrium in the human insulin/insulin-like growth factor II region of human chromosome II. Cox NJ, Bell GI, Xiang KS (1988) Am J Hum Genet 43: 495-501 Expression of insulin-like growth factor-I and -II genes in human smooth muscle tumours. Höppener JW, Mosselman S, Roholl PJ, Lambrechts C, Slebos RJ, de Pagter-Holthuizen P, Lips CJ, Jansz HS, Sussenbach JS (1988) EMBO J 7: 1379-85 Mutated beta-catenin evades a microRNA-dependent regulatory loop. Veronese A, Visone R, Consiglio J, Acunzo M, Lupini L, Kim T, Ferracin M, Lovat F, Miotto E, Balatti V, D'Abundo L, Gramantieri L, Bolondi L, Pekarsky Y, Perrotti D, Negrini M, Croce CM (2011) Proc Natl Acad Sci U S A 108: 4840-5 Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Lee MP, DeBaun MR, Mitsuya K, Galonek HL, Brandenburg S, Oshimura M, Feinberg AP (1999) Proc Natl Acad Sci U S A 96: 5203-8 Apa I and Sst I RFLPs at the insulin-like growth factor II (IGF2) locus on chromosome 11. Xiang K, Cox NJ, Bell GI (1988) Nucleic Acids Res 16: 3599 YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells. Dey A, Robitaille M, Remke M, Maier C, Malhotra A, Gregorieff A, Wrana JL, Taylor MD, Angers S, Kenney AM (2016) Oncogene 35: 4256-68 Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer. Cheng YW, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F (2010) Int J Cancer 127: 568-77 Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation. Gong Y, Ma Y, Sinyuk M, Loganathan S, Thompson RC, Sarkaria JN, Chen W, Lathia JD, Mobley BC, Clark SW, Wang J (2016) Neuro Oncol 18: 48-57 Functional characterization of a testis-specific DNA binding activity at the H19/Igf2 imprinting control region. Bowman AB, Levorse JM, Ingram RS, Tilghman SM (2003) Mol Cell Biol 23: 8345-51 Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3. Fowke JH, Matthews CE, Yu H, Cai Q, Cohen S, Buchowski MS, Zheng W, Blot WJ (2010) Endocr Relat Cancer 17: 51-60 Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Malin A, Dai Q, Yu H, Shu XO, Jin F, Gao YT, Zheng W (2004) Cancer 100: 694-700 Organ-specific defects in insulin-like growth factor and insulin receptor signaling in late gestational asymmetric intrauterine growth restriction in Cited1 mutant mice. Novitskaya T, Baserga M, de Caestecker MP (2011) Endocrinology 152: 2503-16 IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study. Deming SL, Ren Z, Cai Q, Shu XO, Wen W, Long JR, Gao YT, Zheng W (2008) Cancer Epidemiol Biomarkers Prev 17: 255-7 Insulin-like growth factors and breast cancer risk in Chinese women. Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W (2002) Cancer Epidemiol Biomarkers Prev 11: 705-12 Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions. Guo YS, Jin GF, Townsend CM, Zhang T, Sheng HM, Beauchamp RD, Thompson JC (1995) J Am Coll Surg 181: 145-54 Expression of insulin-like growth factor-I and -II genes in rat medullary thyroid carcinoma. Höppener JW, Steenbergh PH, Slebos RJ, de Pagter-Holthuizen P, Roos BA, Jansen M, Van den Brande JL, Sussenbach JS, Jansz HS, Lips CJ (1987) FEBS Lett 215: 122-6 Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. Kubasiak JC, Seder CW, Pithadia R, Basu S, Fhied C, Phillips WW, Daly S, Shersher DD, Yoder MA, Chmielewski G, Edell ES, Maldonado F, Liptay MJ, Borgia JA (2015) J Thorac Cardiovasc Surg 149: 727-34.e1-3; discussion 734 IGF-II promoter methylation and ovarian cancer prognosis. Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ, Yu H (2007) J Cancer Res Clin Oncol 133: 713-23 Mutations in the IGF-II pathway that confer resistance to lytic reovirus infection. Sheng J, Organ EL, Hao C, Wells KS, Ruley HE, Rubin DH (2004) BMC Cell Biol 5: 32 IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics. Qian B, Katsaros D, Lu L, Canuto EM, Benedetto C, Beeghly-Fadiel A, Yu H (2011) Oncol Rep 25: 203-13
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.